This protocol applies to children with anogenital lichen sclerosus whose condition did not respond adequately to an initial topical steroid course, as assessed at the 3-month review.
The patient is a child with anogenital lichen sclerosus. Age is the defining characteristic of this management pathway, and treatment selection at this stage reflects the specific needs of paediatric patients.
A topical steroid applied to the genital skin — following a structured reducing schedule — was reviewed at 3 months without achieving an adequate treatment response. This protocol defines the next management step after that point of failure.
Management at this stage involves a topical ointment applied to the anogenital skin. The complete regimen — including the specific agent, application instructions, and follow-up plan — is set out in the full structured protocol.
DOI: 10.1111/jdv.18102
Topical tacrolimus 0.03% ointment appears to be an effective treatment for children (probably mainly in girls) with anogenital LS and as maintenance treatment (twice a week), possibly reducing recurrences.
View source ↗